Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ABA.L (ABA) Regulatory News

Date Source Headline
29th Jan 2016 11:00 am RNS Change of Registered Office
25th Jan 2016 7:00 am RNS Entering Partnering Discussions
4th Dec 2015 11:42 am RNS Grant of Share Options
1st Dec 2015 3:06 pm RNS Holding(s) in Company
5th Nov 2015 7:00 am RNS Successful Completion of PoC for OXPzero Ibuprofen
22nd Sep 2015 7:00 am RNS Interim results for the 6 months to 30 June 2015
16th Sep 2015 7:00 am RNS Notice of Interim Results
12th Aug 2015 7:00 am RNS Preliminary PK Data & Initiation of Further Study
31st Jul 2015 7:00 am RNS Results from Pilot Clinical Study of OXP500
16th Jul 2015 7:00 am RNS Initiation of Pilot Clinical Study
16th Jul 2015 7:00 am RNS Initiation of Pilot Clinical Study for Ibuprofen
6th Jul 2015 12:07 pm RNS Holding(s) in Company
30th Jun 2015 2:57 pm RNS Holding(s) in Company
30th Jun 2015 11:21 am RNS Holding(s) in Company
30th Jun 2015 11:02 am RNS Holding(s) in Company
30th Jun 2015 11:02 am RNS Holding(s) in Company
29th Jun 2015 4:02 pm RNS Holding(s) in Company
29th Jun 2015 2:13 pm RNS Holding(s) in Company
24th Jun 2015 3:37 pm RNS Result of GM
9th Jun 2015 7:00 am RNS Posting of Circular and Notice of GM
3rd Jun 2015 8:20 am RNS Grant of Share Options
2nd Jun 2015 7:00 am RNS Proposed Placing
15th May 2015 7:22 am RNS Ibuprofen progressing to proof of concept trial
13th May 2015 7:00 am RNS PK Results for OXPzero Naproxen vs. Naprosyn
15th Apr 2015 5:21 pm RNS Holding(s) in Company
27th Mar 2015 7:00 am RNS Successful Pilot Clinical Study
9th Mar 2015 7:00 am RNS Grant of Share Options
5th Mar 2015 8:32 am RNS Initiation of PK Study of OXPzeroTM Naproxen
5th Mar 2015 7:00 am RNS Final Results & Notice of AGM
30th Jan 2015 7:00 am RNS NSAIDs Programme & Year End Financial Review
20th Jan 2015 7:00 am RNS Naproxen Progresses into Proof of Concept Trials
8th Jan 2015 7:00 am RNS Optimisation of OXP001 & progression to study
20th Nov 2014 8:21 am RNS Grant of Share Options
29th Sep 2014 7:01 am RNS Interim results for the six months to 30 June 2014
19th Sep 2014 7:00 am RNS Notice of Results
15th Sep 2014 7:00 am RNS Progression of Reduced Gastric Irritation Naproxen
16th Jul 2014 7:00 am RNS Appointment of Non-Executive Board Director
18th Jun 2014 4:11 pm RNS Result of AGM
17th Jun 2014 7:00 am RNS Chew Product - Line Extension
2nd Jun 2014 7:00 am RNS Positive Results from Pilot Clinical Study
FTSE 100 Latest
Value10,369.75
Change60.53